Skip to main content
Log in

IVIG treatment drives costs in patients pre-lung transplantation

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Liu A, et al. Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy : 3 Aug 2013. Available from: URL: http://dx.doi.org/10.1007/s40259-013-0054-1

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

IVIG treatment drives costs in patients pre-lung transplantation. PharmacoEcon Outcomes News 685, 9 (2013). https://doi.org/10.1007/s40274-013-0654-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0654-5

Navigation